Clinical Trials Logo
  1. Home
  2. Methemoglobinemia
  3. NCT03542760

Acquired Methemoglobinemia Observational Registry — metHb  

Methemoglobinemia Clinical Trial

Official title:
Use of Methylene Blue in Acquired Methemoglobinemia: Prospective Observational Registry (metHb)

Clinical Trial Summary

This prospective, observational registry aims to collect real-world data regarding the safety and efficacy of ProvayBlue® (methylene blue 0.5%) used according to normal standard of care for the treatment of acquired methemoglobinemia. Methylene blue has been used for decades as a rescue medication for the treatment of methemoglobinemia, a rare and potentially life-threatening condition in which elevated levels of methemoglobin impede the delivery of oxygen from blood to body tissues. However, consistent prospective data about the safety and efficacy of this medication are sparse, simply because of the rarity of the disorder. ProvayBlue® received accelerated FDA approval for treatment of acquired methemoglobinemia in 2016. This large, prospective, multi-center observational registry has been initiated to gain more information on the use of methylene blue in the treatment of acquired methemoglobinemia.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03542760
Study type Observational [Patient Registry]
Source Hospital Quality Foundation
Contact
Status Completed
Phase
Start date May 31, 2018
Completion date August 31, 2021
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06309641 - Methemoglobinemia Following Intravenous Iron Treatment
Completed NCT02493283 - Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration Phase 1
Completed NCT02478281 - Safety, Tolerability, and Pharmacokinetic Study of Methylene Blue Following a 1 mg/kg Intravenous Dose in Healthy Adults Phase 1
Active, not recruiting NCT00960050 - Methemoglobinemia in Patients With Childhood Hematologic Cancer or Aplastic Anemia Treated With Dapsone Phase 1
Completed NCT00993694 - Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone N/A
Completed NCT01402869 - Methemoglobin Levels in Generally Anesthetized Pediatric Dental Patients Receiving Local Anesthetics N/A
Completed NCT01766999 - Methemoglobinemia After Liposuction - Diagnostic by Pulse Oximetry and Blood Gas Analysis.